Bicycle Therapeutics (BCYC) Other Non-Current Liabilities (2018 - 2026)

Bicycle Therapeutics has reported Other Non-Current Liabilities for 9 years, with the latest figure at $973000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 12.81% year-over-year to $973000.0; the trailing twelve-month figure through Mar 2026 stood at $973000.0 (down 12.81% YoY), and the FY2025 full-year result was $1.0 million, down 7.94% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $973000.0, down from $1.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $6.0 million in Q3 2024, with the low at $973000.0 in Q1 2026.
• Historically, Other Non-Current Liabilities has averaged $3.1 million across 5 years, with a median of $3.4 million in 2022.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities soared 38.16% — and 2025, when it plunged 81.67%.
• Bicycle Therapeutics' Other Non-Current Liabilities stood at $3.8 million in 2022, then gained by 19.59% to $4.6 million in 2023, then tumbled by 75.52% to $1.1 million in 2024, then retreated by 7.94% to $1.0 million in 2025, then dropped by 5.72% to $973000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $973000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.